Comment on: TODAY Study Group. Effects of Metformin, Metformin Plus Rosiglitazone, and Metformin Plus Lifestyle on Insulin Sensitivity and β-Cell Function in TODAY. Diabetes Care 2013;36:1749–1757
Year: 2013
Type: letter
Abstract: W e read with great interest theTODAY study articles on adoles-cent diabetes and commend the editors of Diabetes Care for “sounding the alarm ” about the impending adoles-cent diabetes epidemic in the June issue. Ten years ago, Narayan et al. (1) modeled a scenario where young people diagnosed with type 2 diabetes could expect to lose.15 years of relative life expectancy and.25 years of quality-adjusted life years. The TODAY study investigators, by quantifying micro- and macrovascular risk characteristics in young people with diabetes, have made these predictions look disturbingly probable. Equally sobering are the actual car-
Source: Diabetes Care
DOI: 10.2337/dc13-1426
Institutions: University of Otago, University of Auckland
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W2136491926
